Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Notice to applicants for US job openings. Learn More
Showing 2492 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Representante de Ventas, Guanajuato Cardiometabólica Gobierno Regular (Sales), Full time | Innovative Medicines | Mexico +Alternative Locations | INSURGENTES | Jun 18, 2025 |
| Representante de Ventas, Guanajuato Cardiometabólica Gobierno Regelmatig (Verkoop), Full time | Innovative Medicines | Mexico +Alternative Locations | INSURGENTES | Jun 18, 2025 |
| Representante de Ventas, Guanajuato Cardiometabólica Gobierno Regular (Sales), Full time | Innovative Medicines | Mexico +Alternative Locations | INSURGENTES | Jun 18, 2025 |
| Representante de Ventas, Guanajuato Cardiometabólica Gobierno Redni sodelavec (prodaja), Full time | Innovative Medicines | Mexico +Alternative Locations | INSURGENTES | Jun 18, 2025 |
| Representante de Ventas, Guanajuato Cardiometabólica Gobierno Kadrolu (Satış), Full time | Innovative Medicines | Mexico +Alternative Locations | INSURGENTES | Jun 18, 2025 |
| Representante de Ventas, Guanajuato Cardiometabólica Gobierno 正式（销售）, Full time | Innovative Medicines | Mexico +Alternative Locations | INSURGENTES | Jun 18, 2025 |
| (高级）医药代表 /（资深）产品专员 正式（销售）, Full time | Universal Hierarchy Node | China | Xiamen (Fujian Province) | Jun 18, 2025 |
| AD, Thought Leader Liaison Renal - South - Remote Regular, Full time | Universal Hierarchy Node | USA +Alternative Locations | Field Non-Sales (USA) | Jun 17, 2025 |
| S&O Non-Drug Projects Governance Principal Analyst Regular, Full time | Innovative Medicines | India | Hyderabad (Office) | Jun 17, 2025 |
| Senior Expert Science & Technology - I Regular, Full time | Innovative Medicines | China | Changshu (Jiangsu Province) | Jun 17, 2025 |